Genesis Private Wealth’s Sanofi SNY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$326K Sell
7,644
-412
-5% -$18.4K 0.09% 118
2026
Q1
$388K Buy
8,056
+1,732
+27% +$80.8K 0.12% 100
2025
Q4
$306K Buy
6,324
+557
+10% +$27.6K 0.1% 121
2025
Q3
$272K Sell
5,767
-765
-12% -$36.9K 0.11% 107
2025
Q2
$316K Buy
6,532
+71
+1% +$3.63K 0.15% 84
2025
Q1
$358K Buy
6,461
+2,211
+52% +$120K 0.19% 65
2024
Q4
$205K Buy
+4,250
New +$216K 0.11% 131

Other funds holding SNY

Genesis Private Wealth's SNY Position: Q2 2026 in Review

Genesis Private Wealth reduced its Sanofi (SNY) stake by 5.1% in Q2 2026, selling an estimated $18.4K and leaving 7,644 shares worth $326K. The position accounts for 0.09% of the portfolio, ranked #118.

Genesis Private Wealth first reported a position in SNY in Q4 2024 and has held it in 7 quarters since. The position peaked at $388K in Q1 2026. 122 funds tracked by Wall St. Rank hold SNY as of Q2 2026.

  • Genesis Private Wealth held 7,644 shares of Sanofi worth $326K as of Q2 2026.
  • Genesis Private Wealth sold 412 Sanofi shares in Q2 2026, an estimated $18.4K.
  • Sanofi made up 0.09% of Genesis Private Wealth's portfolio in Q2 2026, its #118 holding.
  • Genesis Private Wealth first reported a position in Sanofi in Q4 2024 and has held it in 7 quarters since.
  • Genesis Private Wealth's Sanofi position peaked at $388K in Q1 2026.
  • 122 funds tracked by Wall St. Rank held Sanofi as of Q2 2026.

Based on Genesis Private Wealth's 13F filing for Q2 2026, filed 13 Jul 2026.